AR083756A1 - Formas solidas del 3-(4-(aminometil)-1-(5-metil-7h-pirrolo[2,3-d]pirimidin-4-il)piperidin-4-carboxamido)fenil dimetilcarbamato - Google Patents

Formas solidas del 3-(4-(aminometil)-1-(5-metil-7h-pirrolo[2,3-d]pirimidin-4-il)piperidin-4-carboxamido)fenil dimetilcarbamato

Info

Publication number
AR083756A1
AR083756A1 ARP110104111A ARP110104111A AR083756A1 AR 083756 A1 AR083756 A1 AR 083756A1 AR P110104111 A ARP110104111 A AR P110104111A AR P110104111 A ARP110104111 A AR P110104111A AR 083756 A1 AR083756 A1 AR 083756A1
Authority
AR
Argentina
Prior art keywords
methyl
piperidin
crystalline compound
carboxamido
pyrrolo
Prior art date
Application number
ARP110104111A
Other languages
English (en)
Spanish (es)
Inventor
Paul Susan Margaret De
Qun Li
Haiming Zhang
Original Assignee
Lexicon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lexicon Pharmaceuticals Inc filed Critical Lexicon Pharmaceuticals Inc
Publication of AR083756A1 publication Critical patent/AR083756A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP110104111A 2010-11-05 2011-11-04 Formas solidas del 3-(4-(aminometil)-1-(5-metil-7h-pirrolo[2,3-d]pirimidin-4-il)piperidin-4-carboxamido)fenil dimetilcarbamato AR083756A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41060210P 2010-11-05 2010-11-05

Publications (1)

Publication Number Publication Date
AR083756A1 true AR083756A1 (es) 2013-03-20

Family

ID=45002136

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110104111A AR083756A1 (es) 2010-11-05 2011-11-04 Formas solidas del 3-(4-(aminometil)-1-(5-metil-7h-pirrolo[2,3-d]pirimidin-4-il)piperidin-4-carboxamido)fenil dimetilcarbamato

Country Status (16)

Country Link
US (1) US8735408B2 (cg-RX-API-DMAC7.html)
EP (1) EP2635584A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013541588A (cg-RX-API-DMAC7.html)
KR (1) KR20140003433A (cg-RX-API-DMAC7.html)
CN (1) CN103298815A (cg-RX-API-DMAC7.html)
AR (1) AR083756A1 (cg-RX-API-DMAC7.html)
AU (1) AU2011323371A1 (cg-RX-API-DMAC7.html)
BR (1) BR112013011094A2 (cg-RX-API-DMAC7.html)
CA (1) CA2817112A1 (cg-RX-API-DMAC7.html)
IL (1) IL225884A0 (cg-RX-API-DMAC7.html)
MX (1) MX2013004923A (cg-RX-API-DMAC7.html)
RU (1) RU2013125755A (cg-RX-API-DMAC7.html)
SG (1) SG190098A1 (cg-RX-API-DMAC7.html)
TW (1) TW201302754A (cg-RX-API-DMAC7.html)
WO (1) WO2012061565A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201302996B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015150337A1 (en) 2014-04-01 2015-10-08 Amakem Nv Lim kinase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI439457B (zh) * 2007-09-28 2014-06-01 Lexicon Pharmaceuticals Inc (s)-2-胺基-3-(4-(2-胺基-6-((r)-1-(4-氯-2-(3-甲基-1h-吡唑-1-基)苯基)-2,2,2-三氟乙氧)-嘧啶-4-基)苯基)丙酸乙酯之固體形式與其使用方法
EP2297153B1 (en) * 2008-04-21 2015-05-27 Lexicon Pharmaceuticals, Inc. Limk2 inhibitors, compositions comprising them, and methods of their use

Also Published As

Publication number Publication date
RU2013125755A (ru) 2014-12-10
CA2817112A1 (en) 2011-11-05
TW201302754A (zh) 2013-01-16
JP2013541588A (ja) 2013-11-14
WO2012061565A1 (en) 2012-05-10
ZA201302996B (en) 2014-06-25
US20120122898A1 (en) 2012-05-17
CN103298815A (zh) 2013-09-11
BR112013011094A2 (pt) 2016-08-23
SG190098A1 (en) 2013-06-28
IL225884A0 (en) 2013-07-31
EP2635584A1 (en) 2013-09-11
MX2013004923A (es) 2013-06-28
AU2011323371A1 (en) 2013-05-23
KR20140003433A (ko) 2014-01-09
US8735408B2 (en) 2014-05-27

Similar Documents

Publication Publication Date Title
PE20141598A1 (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
AR094997A1 (es) Sales y formas sólidas de (s)-3-(4-((4-(morfolinometil)bencil)oxi)-1-oxoisoindolin-2-il)piperidin-2,6-diona y composiciones que las comprenden y sus usos
CL2011002955A1 (es) Compuestos derivados de 3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]octanonitrilo o heptanonitrilo o sus sales, como inhibidores de jak; procedimiento de preparacion; composicion farmaceutica que los comprende; utiles para el tratamiento de trastornos autoinmunes, cancer, entre otras enfermedades.
MX2019010446A (es) Compuestos de anillos fusionados biciclicos derivados de piridilo como inhibidores de fgfr4.
NI201300134A (es) Compuestos de 2 - ( 2, 4, 5 - anilino sustituido ) pirimidina
PE20170946A1 (es) 2-amino-6-(difluorometil)- 5,5-difluoro-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1
PE20151001A1 (es) Alcoxipirazoles como activadores de guanilato ciclasa soluble
PE20050761A1 (es) Polimorfo cristalino de una sal de bisulfato como antagonista del receptor de trombina
PE20141167A1 (es) Piridopirazinas sustituidas como inhibidores novedosos de ptk
MX2012013206A (es) Inhibidores de quinasa biciclica fusionada.
MX2015008052A (es) Inhibidores de prmt5 y sus usos.
CY1118135T1 (el) Παραγωγα 2-(φαινυλο ή πυριδ-3-υλο) αμινοπυριμιδινης ως ρυθμιστες κινασης lrrk2 για τη θεραπευτικη αντιμετωπιση της νοσου του parkinson
EA201300250A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
UY33353A (es) Compuestos adecuados para el tratamiento de trastornos metabolicos y metodos de preparacion
PE20141380A1 (es) Imidazopiridazinas como inhibidores de quinasa akt
UY32574A (es) Antagonistas del receptor cxcr3
PE20160839A1 (es) Derivados de 4-azaindol
MX2018009503A (es) Sal de trifluoroacetato de agonista de tlr7 y forma cristalina b de la misma, metodos de preparacion y usos.
MX363652B (es) Sintesis de 3-(5-amino-2-metil-4-oxoquinazolin-3(4h)-il)piperidin- 2,6-diona.
NZ605827A (en) Co-crystals and salts of ccr3-inhibitors
EA201991921A1 (ru) Способы получения ag-10, его промежуточных соединений и их солей
EA201791021A1 (ru) 1-[2-(АМИНОМЕТИЛ)БЕНЗИЛ]-2-ТИОКСО-1,2,3,5-ТЕТРАГИДРО-4H-ПИРРОЛО[3,2-d]ПИРИМИДИН-4-ОНЫ КАК ИНГИБИТОРЫ МИЕЛОПЕРОКСИДАЗЫ
BRPI0921595B8 (pt) sal monocloridrato cristalino de 4-[2,4,6-(trifluorfenoximetil)fenil]piperidina, seu processo de preparo e usos
CY1125224T1 (el) Κρυσταλλικες μορφες 1-(3-τριτ-βουτυλο-1-ρ- τολυλο-1η-πυραζολ-5-υλο)-3-(5-φθορο-2-(1-(2- υδροξυαιθυλ)-ινδαζολ-5-υλοξυ)βενζυλ)ουριας υδροχλωρικη
CR11759A (es) Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas

Legal Events

Date Code Title Description
FB Suspension of granting procedure